<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>行舟Drug | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-25T01:20:43+08:00</updated>
  <subtitle>It takes nothing to join the crowd, but it takes everything to stand alone</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>刚刚！CDE公开征求《疫苗临床试验抗体分析方法研究技术指导原则》意见</title>
    <updated>2020-11-24T21:23:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/_YPMNGzjMMYzv-wFttY1gg</id>
    <link href="https://mp.weixin.qq.com/s/_YPMNGzjMMYzv-wFttY1gg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>人乳头瘤病毒疫苗的申报现状及药学研发思考</title>
    <updated>2020-11-24T21:23:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/Zmqy4b6Pi7e_rYZNuGFVnw</id>
    <link href="https://mp.weixin.qq.com/s/Zmqy4b6Pi7e_rYZNuGFVnw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CDE发布《化学药品创新药I期临床试验申请药学共性问题相关技术要求》和《化学药品I期临床试验申请药学研究信息汇总表（修订版）》</title>
    <updated>2020-11-23T20:39:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-23:/s/9MhE9daJWw66aN-h84fpGQ</id>
    <link href="https://mp.weixin.qq.com/s/9MhE9daJWw66aN-h84fpGQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>信达生物宣布苏立信®（阿达木单抗注射液）在中国新适应症获批，治疗多关节型幼年特发性关节炎</title>
    <updated>2020-11-23T20:39:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-23:/s/53zZK2CJUE6ucaHUOw3ytQ</id>
    <link href="https://mp.weixin.qq.com/s/53zZK2CJUE6ucaHUOw3ytQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2019年全国细菌耐药监测报告</title>
    <updated>2020-11-23T20:39:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-23:/s/du1PSrMFQjK4RmsO-h8hkw</id>
    <link href="https://mp.weixin.qq.com/s/du1PSrMFQjK4RmsO-h8hkw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>严重副作用不同疾病的对应手册（面向患者·公众）（46）-粒细胞缺乏症</title>
    <updated>2020-11-22T18:59:54+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-22:/s/jgTHgQhde_qtI-sv8hWLbw</id>
    <link href="https://mp.weixin.qq.com/s/jgTHgQhde_qtI-sv8hWLbw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>肿瘤微环境与免疫治疗耐药的关系及应对</title>
    <updated>2020-11-22T18:59:54+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-22:/s/WQWE9WVslKJLrPNi45ta2g</id>
    <link href="https://mp.weixin.qq.com/s/WQWE9WVslKJLrPNi45ta2g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药物合成反应的后处理经验分享</title>
    <updated>2020-11-22T18:59:54+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-22:/s/wDxozdr4_QVLc6lqO_lVzQ</id>
    <link href="https://mp.weixin.qq.com/s/wDxozdr4_QVLc6lqO_lVzQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>创新药企业加速布局CDK4/6靶点抑制剂</title>
    <updated>2020-11-21T20:06:43+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-21:/s/JQV65srslY-kZ5itFp6Y_A</id>
    <link href="https://mp.weixin.qq.com/s/JQV65srslY-kZ5itFp6Y_A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>注射剂-在工艺研究与验证中的常见技术问题解答【70道问答】</title>
    <updated>2020-11-21T20:06:43+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-21:/s/ALWqrj4GpQUm9oIGinVYEw</id>
    <link href="https://mp.weixin.qq.com/s/ALWqrj4GpQUm9oIGinVYEw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【无菌制剂】最全的药品冻干过程中各关键环节的控制要点</title>
    <updated>2020-11-21T20:06:43+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-21:/s/FX11wMpQKWvCQFeEkiJXqw</id>
    <link href="https://mp.weixin.qq.com/s/FX11wMpQKWvCQFeEkiJXqw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>想申请附条件批准上市，药企该咋办？CDE来发答案！</title>
    <updated>2020-11-20T21:19:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-20:/s/UC3J-ogcm0FUlOOEWP9frg</id>
    <link href="https://mp.weixin.qq.com/s/UC3J-ogcm0FUlOOEWP9frg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【CDE】化学药物分析方法验证的内容和评价</title>
    <updated>2020-11-20T21:19:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-20:/s/vb9OjC179sQ34YCbkWLhHA</id>
    <link href="https://mp.weixin.qq.com/s/vb9OjC179sQ34YCbkWLhHA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>口服固体仿制药经鼻胃管给药体外对比研究的思考</title>
    <updated>2020-11-20T21:19:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-20:/s/g0Njshcozk-3CPKpYI6fLQ</id>
    <link href="https://mp.weixin.qq.com/s/g0Njshcozk-3CPKpYI6fLQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国家药监局药审中心关于发布《药品附条件批准上市技术指导原则（试行）》的通告（2020年第41号）</title>
    <updated>2020-11-19T19:13:40+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-19:/s/SGnrN2Y4vXbpc8HwXPJZqw</id>
    <link href="https://mp.weixin.qq.com/s/SGnrN2Y4vXbpc8HwXPJZqw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>关于发布第三批临床急需境外新药名单的通知</title>
    <updated>2020-11-19T19:13:40+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-19:/s/BqPL3YaRD5-Wlgnxuhf0QA</id>
    <link href="https://mp.weixin.qq.com/s/BqPL3YaRD5-Wlgnxuhf0QA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>首个国产ALK抑制剂！贝达药业「恩沙替尼」获批上市</title>
    <updated>2020-11-19T19:13:40+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-19:/s/a8z0g3g_jnHQdhSVK5q18A</id>
    <link href="https://mp.weixin.qq.com/s/a8z0g3g_jnHQdhSVK5q18A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>我国药品上市许可持有人药物警戒职责分析</title>
    <updated>2020-11-18T18:50:39+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-18:/s/fJr9nLanHP5nYxmhdyTsiA</id>
    <link href="https://mp.weixin.qq.com/s/fJr9nLanHP5nYxmhdyTsiA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药物杂质研究方法详解</title>
    <updated>2020-11-18T18:50:39+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-18:/s/_UOV3Oj1KxrcisuifRq_9w</id>
    <link href="https://mp.weixin.qq.com/s/_UOV3Oj1KxrcisuifRq_9w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>PPT分享｜李靖博士：中国未来十年抗肿瘤小分子药物的研发布局</title>
    <updated>2020-11-18T18:50:39+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-18:/s/kt07FuoHmxUJetRWUuzokQ</id>
    <link href="https://mp.weixin.qq.com/s/kt07FuoHmxUJetRWUuzokQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>